Hyliion Shares Slide After Q2 Results Fall Short Of Revenue Estimates
Hyliion Holdings Corp (NYSE:HYLN) reported second-quarter revenue of $172 thousand, missing the consensus of $370 thousand. Net loss per share…
Why ContextLogic (WISH) Stock Is Sliding After Hours
ContextLogic Inc (NASDAQ: WISH) shares are trading lower in Tuesday's after-hours session after the company reported
Why Catalyst Pharmaceuticals Shares Are Moving Today
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 1.47% at $10.71. Traders and investors are watching for the company’s second-quarter earnings report, confirmed for Tuesday’s after-hours session.
Needham Remains Bullish On Magnachip Semiconductor & Velodyne Lidar
Needham analyst Rajvindra Gill offered his bullish take on two semiconductor stocks.
AST SpaceMobile Stock Is Soaring Today: Here’s Why
AST SpaceMobile Inc (NASDAQ: ASTS) shares are trading higher Tuesday after the company announced that its test satellite has arrived at the launch location for its upcoming planned launch.
Analysts See Softened Timelines For CRISPR Therapeutics’ Sickle Cell Candidate In US
Barclays says that CRISPR Therapeutics AG’s (NASDAQ: CRSP) Q2 FY22 earnings release was largely incremental, highlighting the progress of multiple clinical programs, including the…
Dow Drops Over 100 Points; Verona Pharma Shares Jump
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.
Atara Lays Off 20% Of Its Workforce, Issues Update On Cell Therapies
Atara Biotherapeutics Inc (NASDAQ:ATRA) will reduce cash burn by laying off 20% of its staff and extend the cash…
Why Lemonade Stock Is Surging Today: ‘We Are Fast Approaching The Tipping Point’
Lemonade Inc (NYSE: LMND) shares are trading higher Tuesday after the company reported better-than-expected financial results and issued guidance above analyst estimates.
Heron Shares Jump After Equity Financing, Q2 Earnings
Heron Therapeutics Inc (NASDAQ:HRTX) reported Q2 sales of $27.63 million, +23.1% Y/Y, beating the consensus of $24.31 million. Oncology sales…